SE9303068D0 - New use - Google Patents
New useInfo
- Publication number
- SE9303068D0 SE9303068D0 SE9303068A SE9303068A SE9303068D0 SE 9303068 D0 SE9303068 D0 SE 9303068D0 SE 9303068 A SE9303068 A SE 9303068A SE 9303068 A SE9303068 A SE 9303068A SE 9303068 D0 SE9303068 D0 SE 9303068D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- date
- sec
- patient
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
DK94928538T DK0720483T3 (da) | 1993-09-21 | 1994-09-21 | Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens |
JP7509721A JPH09502973A (ja) | 1993-09-21 | 1994-09-21 | 脳脊髄液中のgh,igf−▲i▼およびigfbp−3の濃度の増加のために用いる成長ホルモン |
US08/602,728 US5736515A (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of GH, IGF-I and IGFBP-3 in cerebrospinal fluid |
CA002168570A CA2168570C (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid |
PT94928538T PT720483E (pt) | 1993-09-21 | 1994-09-21 | Utilizacao de hormona de crescimento no fabrico de um medicamento para o tratamento de lesao cerebral isquemica e demencia |
AT94928538T ATE263573T1 (de) | 1993-09-21 | 1994-09-21 | Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz |
PCT/SE1994/000875 WO1995008345A1 (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid |
NZ274025A NZ274025A (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasing the concentration of GH in cerebrospinal fluid |
ES94928538T ES2218529T3 (es) | 1993-09-21 | 1994-09-21 | Uso de la hormona del crecimiento para la produccion de un medicamento para el tratamiento de lesiones isquemicas en el cerebro y demencia. |
DE69433687T DE69433687T2 (de) | 1993-09-21 | 1994-09-21 | Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz |
AU77933/94A AU683306B2 (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of GH, IGF-I and IGFBP-3 in cerebrospinal fluid |
EP94928538A EP0720483B1 (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone in the manufacture of a medicament for the treatment of ischaemic brain damage and dementia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9303068D0 true SE9303068D0 (sv) | 1993-09-21 |
Family
ID=20391162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
Country Status (13)
Country | Link |
---|---|
US (1) | US5736515A (sv) |
EP (1) | EP0720483B1 (sv) |
JP (1) | JPH09502973A (sv) |
AT (1) | ATE263573T1 (sv) |
AU (1) | AU683306B2 (sv) |
CA (1) | CA2168570C (sv) |
DE (1) | DE69433687T2 (sv) |
DK (1) | DK0720483T3 (sv) |
ES (1) | ES2218529T3 (sv) |
NZ (1) | NZ274025A (sv) |
PT (1) | PT720483E (sv) |
SE (1) | SE9303068D0 (sv) |
WO (1) | WO1995008345A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025368A (en) * | 1997-02-25 | 2000-02-15 | Celtrix Pharmaceuticals, Inc. | Method for treating the symptoms of chronic stress-related disorders using IGF |
US6015786A (en) * | 1997-02-25 | 2000-01-18 | Celtrix Pharmaceuticals, Inc. | Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
US6514937B1 (en) | 1997-02-25 | 2003-02-04 | Celtrix Pharmaceuticals, Inc. | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
CA2343214A1 (en) | 1998-09-03 | 2000-03-16 | Chris Edward Williams | Neuroprotection |
EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
WO2005014033A1 (en) * | 2003-07-29 | 2005-02-17 | Ares Trading S.A. | Use of human growth hormone in multiple system atrophy |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2974088A (en) * | 1958-07-18 | 1961-03-07 | Merck & Co Inc | Method of preparing growth hormone |
US3118815A (en) * | 1959-09-28 | 1964-01-21 | Upjohn Co | Growth hormone and recovery thereof |
EP0103395A3 (en) * | 1982-08-17 | 1985-05-22 | Biogen N.V. | Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield |
US4521409A (en) * | 1983-10-03 | 1985-06-04 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance ruminant mammary development |
EP0210219B1 (en) * | 1985-01-28 | 1989-04-12 | PARK, Seung Moon | Lighting apparatus for wheels of vehicles |
US4670249A (en) * | 1985-04-12 | 1987-06-02 | International Minerals & Chemical Corp. | Growth-promoting compositions |
US4786501A (en) * | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
IL79681A (en) * | 1985-08-12 | 1991-06-10 | Int Minerals & Chem Corp | Transition metal complexes of growth hormones and their prolonged release compositions |
US4977140A (en) * | 1985-08-23 | 1990-12-11 | Eli Lilly And Company | Injectable sustained release formulation |
IL79765A (en) * | 1985-08-23 | 1992-02-16 | Lilly Co Eli | Injectable sustained release formulations of bovine somatotropin |
US4857506A (en) * | 1987-01-12 | 1989-08-15 | American Cyanamid Company | Sustained release growth hormone compositions for parenteral administration and their use |
US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
NZ223842A (en) * | 1988-03-10 | 1991-07-26 | Amgen Inc | Porcine growth hormone analogues, production using genetic engineering and compositions for promoting growth in mammals |
-
1993
- 1993-09-21 SE SE9303068A patent/SE9303068D0/sv unknown
-
1994
- 1994-09-21 ES ES94928538T patent/ES2218529T3/es not_active Expired - Lifetime
- 1994-09-21 DK DK94928538T patent/DK0720483T3/da active
- 1994-09-21 AU AU77933/94A patent/AU683306B2/en not_active Ceased
- 1994-09-21 NZ NZ274025A patent/NZ274025A/en not_active IP Right Cessation
- 1994-09-21 DE DE69433687T patent/DE69433687T2/de not_active Expired - Lifetime
- 1994-09-21 AT AT94928538T patent/ATE263573T1/de active
- 1994-09-21 EP EP94928538A patent/EP0720483B1/en not_active Expired - Lifetime
- 1994-09-21 PT PT94928538T patent/PT720483E/pt unknown
- 1994-09-21 US US08/602,728 patent/US5736515A/en not_active Expired - Lifetime
- 1994-09-21 JP JP7509721A patent/JPH09502973A/ja active Pending
- 1994-09-21 WO PCT/SE1994/000875 patent/WO1995008345A1/en active IP Right Grant
- 1994-09-21 CA CA002168570A patent/CA2168570C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE263573T1 (de) | 2004-04-15 |
DE69433687T2 (de) | 2005-03-17 |
AU7793394A (en) | 1995-04-10 |
US5736515A (en) | 1998-04-07 |
WO1995008345A1 (en) | 1995-03-30 |
CA2168570A1 (en) | 1995-03-30 |
DK0720483T3 (da) | 2004-08-09 |
ES2218529T3 (es) | 2004-11-16 |
JPH09502973A (ja) | 1997-03-25 |
CA2168570C (en) | 2009-04-07 |
PT720483E (pt) | 2004-08-31 |
NZ274025A (en) | 2005-03-24 |
EP0720483A1 (en) | 1996-07-10 |
EP0720483B1 (en) | 2004-04-07 |
DE69433687D1 (de) | 2004-05-13 |
AU683306B2 (en) | 1997-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
ES2140463T3 (es) | Prevencion y tratamiento de la neuropatia periferica. | |
DE69121715T2 (de) | Die kombination des wachshormons und des insulin-ähnlichen wachstumsfaktors-i stimuliert das wachstum | |
DE69230112T2 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ATE288444T1 (de) | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren | |
EP0798000A3 (en) | Treating disorders by application of insulin-like growth factors and analogs | |
ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
ATE184776T1 (de) | Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten | |
DK0790824T3 (da) | 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens | |
NO940180D0 (no) | Anvendelse av IGF-I | |
DE69316013T2 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
MX9301387A (es) | Metodo y composicion para el tratamiento de osteoporosis. | |
SE9303068D0 (sv) | New use | |
DE68918944D1 (de) | Künstliche rezeptor-analoge. | |
CA2074166A1 (en) | Method for treating intestinal diseases | |
DE69332541D1 (de) | Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie | |
DE69221725D1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
DE69231036T2 (de) | Verfahren zur behandlung von patienten mit chronischer lebererkrankung | |
DE69023006T2 (de) | Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen. | |
DE69427116T2 (de) | Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis | |
ATE107165T1 (de) | Verwendung von macrolactonen als antiallergica. | |
SE9002731D0 (sv) | Product comprising growth factor | |
DE69315840D1 (de) | Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor | |
DE69220229D1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder |